首页> 外文期刊>CNS oncology. >Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab
【24h】

Radiographic patterns of recurrence and pathologic correlation in malignant gliomas treated with bevacizumab

机译:贝伐单抗治疗恶性神经胶质瘤的影像学复发及病理相关性

获取原文
       

摘要

Interpretation?of MRI abnormalities in patients with malignant gliomas (MG) treated with bevacizumab is challenging. Recent reports describe quantitative analyses of diffusion-weighted imaging abnormalities not available in standard clinical settings, to differentiate tumor recurrence from treatment necrosis. We retrospectively reviewed bevacizumab treated MG patients who underwent surgery or autopsy to correlate radiographic recurrence patterns with pathologic findings. 32 patients with MG (26 glioblastoma, three anaplastic astrocytoma and three anaplastic oligodendroglioma) were identified. Recurrence patterns: local enhancing (n?=?23), distant enhancing (n?=?1), nonenhancing (n?=?7) and leptomeningeal (n?=?1). Histology: tumor (n?=?25), mixed tumorecrosis (n?=?5) and all necrosis (n?=?2). On diffusion-weighted imaging, 5/32 had restricted diffusion (three mixed and two necrosis). Irrespective of radiographic recurrence pattern, tumor was found in 94% of cases. Restricted diffusion correlated with nec...
机译:贝伐单抗治疗的恶性神经胶质瘤(MG)患者的MRI异常的解释具有挑战性。最近的报告描述了标准临床条件下无法获得的弥散加权成像异常的定量分析,以区分肿瘤复发与治疗坏死。我们回顾性地回顾了接受贝伐单抗治疗的MG患者,他们接受了手术或尸检,以将放射学复发模式与病理结果相关联。确定了32例MG患者(26例胶质母细胞瘤,3例间变性星形细胞瘤和3例间变性少突胶质细胞瘤)。复发方式:局部增强(n≥23),远处增强(n≥1),不增强(n = 7)和软脑膜(n = 1)。组织学:肿瘤(n≥25),混合的肿瘤/坏死(n≥5)和所有坏死(n≥2)。在扩散加权成像中,5/32具有受限的扩散(三个混合和两个坏死)。不考虑放射学复发模式,在94%的病例中发现了肿瘤。与其他相关的受限扩散

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号